Regulation of amino acid transporters in the rat remnant kidney

Nephrology Dialysis Transplantation

Volumn 24, Issue 7, 2009, Pages 2058-2067

  Amaral, João S ^a   Pinho, Maria João ^a   Soares Da Silva, Patrício ^a  

^a Institute of Pharmacology and Therapeutics   (Portugal)

Author keywords

LAT1; LAT2; Renal dopaminergic system; Renal mass reduction

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINO ACID TRANSPORTER; CATECHOLAMINE; DOPAMINE; LEVODOPA; PROTEIN 4F2HC; PROTEIN LAT1; PROTEIN LAT2; SODIUM; SODIUM PROTON EXCHANGE PROTEIN 3; UNCLASSIFIED DRUG; UREA;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DOPAMINERGIC SYSTEM; GENE EXPRESSION; KIDNEY DEVELOPMENT; KIDNEY MASS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SODIUM BLOOD LEVEL; SODIUM EXCRETION; SODIUM URINE LEVEL; UNINEPHRECTOMY; UREA BLOOD LEVEL; UREMIA; URINE VOLUME;

AMINO ACID TRANSPORT SYSTEMS; ANIMALS; KIDNEY; NEPHRECTOMY; RATS; RATS, WISTAR;

EID: 67651100886     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn752     Document Type: Article

References (68)

1. Davis CL, Delmonico FL. Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 2005; 16: 2098-2110
2. Ommen ES, Winston JA, Murphy B. Medical risks in living kidney donors: absence of proof is not proof of absence. Clin J Am Soc Nephrol 2006; 1: 885-895
3. Buerkert J, Martin D, Prasad J et al. Response of deep nephrons and the terminal collecting duct to a reduction in renal mass. Am J Physiol 1979; 236: F454-F464
4. Fine LG, Schlondorff D, Trizna W et al. Functional profile of the isolated uremic nephron. Impaired water permeability and adenylate cyclase responsiveness of the cortical collecting tubule to vasopressin. J Clin Invest 1978; 61: 1519-1527
5. Hayslett JP, Kashgarian M, Epstein FH. Functional correlates of compensatory renal hypertrophy. J Clin Invest 1968; 47: 774-799
6. Hayslett JP. Functional adaptation to reduction in renal mass. Physiol Rev 1979; 59: 137-164
7. Sampaio-Maia B, Serrao P, Vieira-Coelho MA et al. Differences in the renal dopaminergic system activity between Wistar rats from two suppliers. Acta Physiol Scand 2003; 178: 83-89
8. Sampaio-Maia B, Serrao P, Guimaraes JT et al. Renal dopaminergic system activity in the rat remnant kidney. Nephron Exp Nephrol 2005; 99: e46-e55
9. Vieira-Coelho MA, Serrao P, Guimaraes JT et al. Concerted action of dopamine on renal and intestinal Na(+)-K(+)-ATPase in the rat remnant kidney. Am J Physiol Renal Physiol 2000; 279: F1033-F1044
10. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000; 62: 621-647
11. Jose PA, Eisner GM, Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 2002; 11: 87-92
12. + exchange in isolated single proximal tubules of spontaneously hypertensive rats. J Hypertens 1992; 10: 969-978
13. 0,+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines. J Membr Biol 2002; 186: 63-80
14. Li XX, Xu J, Zheng S et al. D(1) dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1650-R1656
15. + exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells. Br J Pharmacol 2004; 142: 1343-1353
16. Xu J, Li XX, Albrecht FE et al. Dopamine(1) receptor, Gs(alpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension. Hypertension 2000; 36: 395-399
17. Soares-da-Silva P, Fernandes MH. Sodium-dependence and ouabain-sensitivity of the synthesis of dopamine in renal tissues of the rat. Br J Pharmacol 1992; 105: 811-816
18. Soares-da-Silva P, Fernandes MH, Pestana M. Studies on the role of sodium on the synthesis of dopamine in the rat kidney. J Pharmacol Exp Ther 1993; 264: 406-414
19. Soares-da-Silva P, Pestana M, Fernandes MH. Involvement of tubular sodium in the formation of dopamine in the human renal cortex. JAm Soc Nephrol 1993; 3: 1591-1599
20. Ball SG, Oats NS, Lee MR. Urinary dopamine in man and rat: effects of inorganic salts on dopamine excretion. Clin Sci Mol Med 1978; 55: 167-173
21. Goldstein DS, Stull R, Eisenhofer G et al. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci (Lond) 1989; 76: 517-522
22. Grossman E, Hoffman A, Tamrat M et al. Endogenous dopa and dopamine responses to dietary salt loading in salt-sensitive rats. J Hypertens 1991; 9: 259-263
23. Vieira-Coelho MA, Hussain T, Kansra V et al. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats. Hypertension 1999; 34: 666-672
24. Hayashi M, Yamaji Y, Kitajima W et al. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 1990; 258: F28-F33
25. + intake on dopamine-induced inhibition of renal cortical Na(+)-K(+)-ATPase. Am J Physiol 1990; 258: F52-F60
26. Soares-da-Silva P, Fernandes MH. Regulation of dopamine synthesis in the rat kidney. J Auton Pharmacol 1990; 10(Suppl 1): s25-s30
27. Pinto-do OP, Soares-da-Silva P. Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules. Br J Pharmacol 1996; 118: 741-747
28. Soares-da-Silva P, Fernandes MH, Pinto-do OP. Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br J Pharmacol 1994; 112: 611-615
29. Soares-Da-Silva P, Serrao MP, Vieira-Coelho MA. Apical and basolateral uptake and intracellular fate of dopamine precursor L-dopa in LLC-PK1 cells. Am J Physiol 1998; 274: F243-F251
30. Soares-da-Silva P, Serrao P, Fraga S et al. Expression and function of LAT1, a neutral amino acid exchanger, in renal porcine epithelial cell line LLC-PK. Acta Physiol Scand 2005; 185: 71-78
31. Soares-da-Silva P, Serrao MP. High-and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells. Am J Physiol Renal Physiol 2004; 287: F252-F261
32. Soares-Da-Silva P, Serrao MP, Pinho MJ et al. Cloning and gene silencing of LAT2, the L-3,4-dihydroxyphenylalanine (1-DOPA) transporter, in pig renal LLC-PK1 epithelial cells. FASEB J 2004; 18: 1489-1498
33. Pinho MJ, Serrao MP, Gomes P et al. Over-expression of renal LAT1 and LAT2 and enhanced L-DOPA uptake in SHR immortalized renal proximal tubular cells. Kidney Int 2004; 66: 216-226
34. Pinho MJ, Serrao MP, Soares-da-Silva P. High-salt intake and the renal expression of amino acid transporters in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2007; 292: F1452-F1463
35. Fuchs BC, Bode BP. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol 2005; 15: 254-266
36. Pineda M, Fernandez E, Torrents D et al. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. JBiolChem 1999; 274: 19738-19744
37. +-independent neutral amino acid transporter with broad substrate selectivity. JBiolChem 1999; 274: 19745-19751
38. Nakamura E, Sato M, Yang H et al. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. JBiolChem 1999; 274: 3009-3016
39. Lee MR. Dopamine and the kidney: ten years on. Clin Sci (Lond) 1993; 84: 357-375
40. Akker SA, Smith PJ, Chew SL. Nuclear post-transcriptional control of gene expression. J Mol Endocrinol 2001; 27: 123-131
41. Finkelstein FO, Hayslett JP. Role of medullary structures in the functional adaptation of renal insufficiency. Kidney Int 1974; 6: 419-425
42. +-ATPase in the rat: effects of reduction of renal mass. Am J Physiol 1980; 239: F281-F288
43. Schon DA, Silva P, Hayslett JP. Mechanism of potassium excretion in renal insufficiency. Am J Physiol 1974; 227: 1323-1330
44. Mujais SK, Kurtzman NA. Regulation of renal Na-K-ATPase in the rat: effect of uninephrectomy. Am J Physiol 1986; 251: F506-F512
45. Greger R. Physiology of renal sodium transport. Am J Med Sci 2000; 319: 51-62
46. Knepper MA, Brooks HL. Regulation of the sodium transporters NHE3, NKCC2 and NCC in the kidney. Curr Opin Nephrol Hypertens 2001; 10: 655-659
47. Storey BT, Fugere C, Lesieur-Brooks A et al. Adenoviral modulation of the tumor-associated system L amino acid transporter, LAT1, alters amino acid transport, cell growth and 4F2/CD98 expression with cell-type specific effects in cultured hepatic cells. Int J Cancer 2005; 117: 387-397
48. Kanai Y, Segawa H, Miyamoto K et al. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). JBiolChem 1998; 273: 23629-23632
49. Bode BP. Recent molecular advances in mammalian glutamine transport. JNutr 2001; 131: 2475S-2485S; discussion 2486S-2487S
50. Verrey F., System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch 2003; 445: 529-533
51. del Amo EM, Urtti A, Yliperttula M. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur J Pharm Sci 2008; 35: 161-174
52. Weissgarten J, Berman S, Efrati S et al. Apoptosis and proliferation of mesangial cells isolated from kidneys undergoing compensatory growth following contralateral nephrectomy: role of the reninangiotensin system. Med Sci Monit 2007; 13: BR16-BR23
53. Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999; 56: 393-405
54. Liu B, Preisig PA. Compensatory renal hypertrophy is mediated by a cell cycle-dependent mechanism. Kidney Int 2002; 62: 1650-1658
55. Chen JK, Chen J, Neilson EG et al. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J Am Soc Nephrol 2005; 16: 1384-1391
56. Pfaller W, Seppi T, Ohno A et al. Quantitative morphology of renal cortical structures during compensatory hypertrophy. Exp Nephrol 1998; 6: 308-319
57. Seyer-Hansen K, Gundersen HJ, Osterby R. Stereology of the rat kidney during compensatory renal hypertrophy. Acta Pathol Microbiol Immunol Scand [A] 1985; 93: 9-12
58. Pillebout E, Burtin M, Yuan HT et al. Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions. Am J Pathol 2001; 159: 547-560
59. Babic N, Huskic J, Mornjakovic Z et al. Stereologic analysis of renal cortical structures during compensatory hypertrophy in rats. Med Arh 2004; 58: 75-78
60. Yanagida O, Kanai Y, Chairoungdua A et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 2001; 1514: 291-302
61. +LAT2 requires different domains. Biochem J 2001; 355: 725-731
62. Franca R, Veljkovic E, Walter S et al. Heterodimeric amino acid transporter glycoprotein domains determining functional subunit association. Biochem J 2005; 388: 435-443
63. Wagner CA, Lang F, Broer S. Function and structure of heterodimeric amino acid transporters. Am J Physiol Cell Physiol 2001; 281: C1077-C1093
64. Rossier G, Meier C, Bauch C et al. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine. JBiolChem 1999; 274: 34948-34954
65. Soares-da-Silva P. Source and handling of renal dopamine: its physiological importance. News Physiol Sci 1994; 9: 128-134
66. Moreira-Rodrigues M, Sampaio-Maia B, Moura M et al. Renal dopaminergic system activity in uninephrectomized rats up to 26 weeks after surgery. Am J Nephrol 2007; 27: 232-239
67. Isaac J, Berndt TJ, Thothathri V et al. Catecholamines and phosphate excretion by the remnant kidney. Kidney Int 1993; 43: 1021-1026
68. Carlstrom M, Sallstrom J, Skott O et al. Uninephrectomy in young age or chronic salt loading causes salt-sensitive hypertension in adult rats. Hypertension 2007; 49: 1342-1350